Blockchain Registration Transaction Record
FDA Grants Fast Track to NRx's NRX-100 for Suicidal Depression Treatment
NRx Pharmaceuticals receives FDA Fast Track for NRX-100, targeting suicidal depression, marking a leap in mental health treatment options. Learn more about this breakthrough.

This news is crucial as it highlights a significant advancement in the treatment of suicidal ideation in depression, a condition with limited effective treatments. The FDA's Fast Track designation accelerates the development and review of NRX-100, potentially bringing a much-needed therapy to patients faster. The positive clinical trial results offer hope for individuals suffering from severe depression and suicidal thoughts, emphasizing the importance of innovative treatments in mental health care.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0xf5c899afe7b1e5db705e2501ceabfe71f2709eca63517e58645bcd6ed4fe5160 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | dashsLnX-d6ab90fca8e21690733a4c137f0d138c |